Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 6784689, 11 pages
http://dx.doi.org/10.1155/2016/6784689
Research Article

Antidepressant-Like Effects of Fractions Prepared from Danzhi-Xiaoyao-San Decoction in Rats with Chronic Unpredictable Mild Stress: Effects on Hypothalamic-Pituitary-Adrenal Axis, Arginine Vasopressin, and Neurotransmitters

1Department of Basic Theory of Chinese Medicine, School of Preclinical Medicine, Guangzhou University of Chinese Medicine, 232 Waihuandong Road, Higher Education Mega Center, Panyu District, Guangzhou 510060, China
2Department of Pathophysiology, School of Preclinical Medicine, Guangzhou University of Chinese Medicine, 232 Waihuandong Road, Higher Education Mega Center, Panyu District, Guangzhou 510060, China
3Department of Pathophysiology, School of Preclinical Medicine, Sun Yat-Sen University, 58 Zhongshan Er Road, Guangzhou 510080, China

Received 16 January 2016; Revised 16 May 2016; Accepted 23 May 2016

Academic Editor: Maria Camilla Bergonzi

Copyright © 2016 Li-Li Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Knol, J. W. R. Twisk, A. T. F. Beekman, R. J. Heine, F. J. Snoek, and F. Pouwer, “Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis,” Diabetologia, vol. 49, no. 5, pp. 837–845, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Chen, S.-C. Huang, S.-L. Cai, and W. Hao, “New advances in the biological basis of depression and new targets for antidepressant treatment,” Journal of Clinical Psychiatry, vol. 25, no. 3, pp. 208–210, 2015. View at Google Scholar
  3. J.-M. Liu, F. Shi, and Y.-N. Lv, “Advances in the study of the hypothalamic-pituitary-adrenal axis in the role of antidepression drugs,” Herald of Medicine, vol. 32, no. 1, pp. 56–59, 2013. View at Google Scholar
  4. H.-C. Luo, R.-Q. Qian, X.-Y. Zhao et al., “Clinical observation on effect of danzhi xiaoyao powder in treating depression,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 26, no. 3, pp. 212–214, 2006. View at Google Scholar · View at Scopus
  5. L.-J. Li, “The effect of Danzhi Xiaoyao powder combined with escitalopram on the general recovery in patients with depression after ischemic stroke,” Chinese Journal of Practical Nervous Disease, vol. 18, no. 21, pp. 6–8, 2015. View at Google Scholar
  6. P. Willner, “Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation,” Psychopharmacology, vol. 134, no. 4, pp. 319–329, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Y. Zhu, Q.-Q. Mao, S.-P. Ip et al., “A standardized chinese herbal decoction, kai-xin-san, restores decreased levels of neurotransmitters and neurotrophic factors in the brain of chronic stress-induced depressive rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 149256, 13 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. L.-L. Wu, Y. Liu, Q.-H. Chen, and C. Yan, “Effects of timeshare administration of Jiaweisinisan on biological rhythm of rats with chronic stress,” Chinese Pharmacological Bulletin, vol. 30, no. 6, pp. 867–874, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. R. D. Porsolt, A. Bertin, and M. Jalfre, “Behavioral despair in mice: a primary screening Test for antidepressants,” Archives Internationales de Pharmacodynamie et de Therapie, vol. 229, no. 2, pp. 327–336, 1977. View at Google Scholar · View at Scopus
  10. A. D. E. Zomkowski, A. R. S. Santos, and A. L. S. Rodrigues, “Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test,” Neuroscience Letters, vol. 381, no. 3, pp. 279–283, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Steru, R. Chermat, B. Thierry, and P. Simon, “The tail suspension test: a new method for screening antidepressants in mice,” Psychopharmacology, vol. 85, no. 3, pp. 367–370, 1985. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Archer, “Tests for emotionality in rats and mice: a review,” Animal Behaviour, vol. 21, no. 2, pp. 205–235, 1973. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Yan, Z. W. Xu, Y. Li et al., “Comparative study on effect of liver-regulating, kidney-tonifying and spleen-invigorating recipes on monoamine neurotransmitter in plasma and hypothalamus of rats with chronic psychological stress,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 22, no. 12, pp. 925–928, 2002. View at Google Scholar
  14. C. Yan, L. L. Wu, Z. W. Xu, Y. F. Shi, and Y. Pan, “Effect of Jiaweisinisan on the levels of some aminoacids in hippocampus of rats with chronic stress,” Chinese Journal of Pathophysiology, vol. 21, no. 10, pp. 2032–2034, 2005. View at Google Scholar
  15. J. W. Commissiong, “Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity,” Biochemical Pharmacology, vol. 34, no. 8, pp. 1127–1131, 1985. View at Publisher · View at Google Scholar · View at Scopus
  16. R. K. W. Schwarting and J. P. Huston, “Behavioral concomitants of regional changes in the brain's biogenic amines after apomorphine and amphetamine,” Pharmacology, Biochemistry and Behavior, vol. 41, no. 4, pp. 675–682, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Chen and H. P. Huang, “Stress induced depression and monoaminergic system Homeostasis,” Journal of Biology, vol. 30, no. 1, pp. 78–81, 2013. View at Google Scholar
  18. J. F. Cryan, A. Markou, and I. Lucki, “Assessing antidepressant activity in rodents: recent developments and future needs,” Trends in Pharmacological Sciences, vol. 23, no. 5, pp. 238–245, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. F. Cryan, C. Mombereau, and A. Vassout, “The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice,” Neuroscience and Biobehavioral Reviews, vol. 29, no. 4-5, pp. 571–625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Chen, M. Chen, F. Wang et al., “Antidepressant-like effects of shuyusan in rats exposed to chronic stress: effects on hypothalamic-pituitary-adrenal function,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 940846, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. L. M. Holsen, K. Lancaster, A. Klibanski et al., “HPA-axis hormone modulation of stress response circuitry activity in women with remitted major depression,” Neuroscience, vol. 250, pp. 733–742, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Heuser, “The hypothalamic-pituitary-adrenal system in depression,” Pharmacopsychiatry, vol. 31, no. 1, pp. 10–13, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. S. A. Fraser, K. Kroenke, C. M. Callahan, S. L. Hui, J. W. Williams Jr., and J. Unützer, “Low yield of thyroid-stimulating hormone testing in elderly patients with depression,” General Hospital Psychiatry, vol. 26, no. 4, pp. 302–309, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. C. M. Pariante and S. L. Lightman, “The HPA axis in major depression: classical theories and new developments,” Trends in Neurosciences, vol. 31, no. 9, pp. 464–468, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Martínez-Mota, J. J. Cruz-Martínez, S. Márquez-Baltazar, and A. Fernández-Guasti, “Estrogens participate in the antidepressant-like effect of desipramine and fluoxetine in male rats,” Pharmacology Biochemistry and Behavior, vol. 88, no. 3, pp. 332–340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. P. J. Cowen, “Not fade away: the HPA axis and depression,” Psychological Medicine, vol. 40, no. 1, pp. 1–4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Stemmelin, L. Lukovic, N. Salome, and G. Griebel, “Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415,” Neuropsychopharmacology, vol. 30, no. 1, pp. 35–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Brunner, M. E. Keck, R. Landgraf, M. Uhr, C. Namendorf, and T. Bronisch, “Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results,” European Neuropsychopharmacology, vol. 12, no. 5, pp. 489–494, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J. G. Goekoop, R. F. P. De Winter, R. Wolterbeek, and V. M. Wiegant, “Support for two increased vasopressinergic activities in depression at large and the differential effect of antidepressant treatment,” Journal of Psychopharmacology, vol. 25, no. 10, pp. 1304–1312, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. T. G. Dinan and L. V. Scott, “Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin,” Journal of Anatomy, vol. 207, no. 3, pp. 259–264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. D. H. Root, A. F. Hoffman, C. H. Good et al., “Norepinephrine activates dopamine d4 receptors in the rat lateral habenula,” Journal of Neuroscience, vol. 35, no. 8, pp. 3460–3469, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Goda, T. Otsuka, A. Iwamoto et al., “Serotonin levels in the dorsal raphe nuclei of both chipmunks and mice are enhanced by long photoperiod, but brain dopamine level response to photoperiod is species-specific,” Neuroscience Letters, vol. 593, pp. 95–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Takamura, S. Nakagawa, T. Masuda et al., “The effect of dopamine on adult hippocampal neurogenesis,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 50, pp. 116–124, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Berton and E. J. Nestler, “New approaches to antidepressant drug discovery: beyond monoamines,” Nature Reviews Neuroscience, vol. 7, no. 2, pp. 137–151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Sanacora, G. Treccani, and M. Popoli, “Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders,” Neuropharmacology, vol. 62, no. 1, pp. 63–77, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Zhao, C. Wang, J.-F. Zhang et al., “Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor,” Psychopharmacology, vol. 231, no. 10, pp. 2171–2187, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Sanacora, R. Gueorguieva, C. N. Epperson et al., “Subtype-specific alterations of γ-aminobutyric acid and glutamate in patients with major depression,” Archives of General Psychiatry, vol. 61, no. 7, pp. 705–713, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. W. J. Cubała and J. Landowski, “Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression,” Psychiatria Polska, vol. 40, no. 3, pp. 415–430, 2006. View at Google Scholar · View at Scopus
  39. L. Lanfumey, R. Mongeau, C. Cohen-Salmon, and M. Hamon, “Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders,” Neuroscience and Biobehavioral Reviews, vol. 32, no. 6, pp. 1174–1184, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Barden, “Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression,” Journal of Psychiatry and Neuroscience, vol. 29, no. 3, pp. 185–193, 2004. View at Google Scholar · View at Scopus
  41. C.-H. Lai and Y.-T. Wu, “Duloxetine's modest short-term influences in subcortical structures of first episode drug-naïve patients with major depressive disorder and panic disorder,” Psychiatry Research - Neuroimaging, vol. 194, no. 2, pp. 157–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Zhang, Y. Fan, Y. Li, H. Zhu, L. Wang, and M.-Y. Zhu, “Chronic social defeat up-regulates expression of the serotonin transporter in rat dorsal raphe nucleus and projection regions in a glucocorticoid-dependent manner,” Journal of Neurochemistry, vol. 123, no. 6, pp. 1054–1068, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. Z. De Miguel, O. Vegas, L. Garmendia, A. Arregi, G. Beitia, and A. Azpiroz, “Behavioral coping strategies in response to social stress are associated with distinct neuroendocrine, monoaminergic and immune response profiles in mice,” Behavioural Brain Research, vol. 225, no. 2, pp. 554–561, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. H. P. Jedema and A. A. Grace, “Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro,” The Journal of Neuroscience, vol. 24, no. 43, pp. 9703–9713, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. A. E. Calogero, R. Bernardini, P. W. Gold, and G. P. Chrousos, “Regulation of rat hypothalamic corticotropin-releasing hormone secretion in vitro: potential clinical implications,” Advances in Experimental Medicine and Biology, vol. 245, pp. 167–181, 1988. View at Publisher · View at Google Scholar · View at Scopus
  46. A. M. Magariños, B. S. McEwen, G. Flügge, and E. Fuchs, “Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews,” The Journal of Neuroscience, vol. 16, no. 10, pp. 3534–3540, 1996. View at Google Scholar · View at Scopus
  47. V. Compère, S. Li, J. Leprince, M. C. Tonon, H. Vaudry, and G. Pelletier, “In vivo action of a new octadecaneuropeptide antagonist on neuropeptide Y and corticotropin-releasing hormone mRNA levels in rat,” Molecular Brain Research, vol. 141, no. 2, pp. 156–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Raber, “Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation: from obesity to memory deficits,” Molecular Neurobiology, vol. 18, no. 1, pp. 1–22, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. R. D. Strous, R. Maayan, and A. Weizman, “The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside,” European Neuropsychopharmacology, vol. 16, no. 3, pp. 155–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Singewald, G.-Y. Zhou, and C. Schneider, “Release of excitatory and inhibitory amino acids from the locus coeruleus of conscious rats by cardiovascular stimuli and various forms of acute stress,” Brain Research, vol. 704, no. 1, pp. 42–50, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Hashimoto, “The role of glutamate on the action of antidepressants,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 7, pp. 1558–1568, 2011. View at Publisher · View at Google Scholar · View at Scopus